Navigation Links
NUCRYST Pharmaceuticals announces 2007 third quarter results
Date:11/7/2007

as NPI 32101.

A more detailed discussion of NUCRYST's 2007 third quarter results can be found in our 10-Q filing which will be available at http://www.sec.gov and http://www.sedar.com. NUCRYST filings are also available at http://www.nucryst.com/Regulatory_Filings.htm.

All figures are in US dollars unless otherwise stated

SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.

Acticoat(TM) is a trademark of Smith & Nephew plc

The financial results in this news release are unaudited and are not a complete disclosure of our quarterly or annual financial results. This news release contains forward-looking statements within the meaning of securities legislation in the United States and Canada (collectively "forward-looking statements"). The words "intends", "focus", "pursuit" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this news release include, but are not limited to, statements about: prospects and plans for supporting the continued growth of the Acticoat(TM) brand and prospects and plans for the development of future products containing our nanocrystalline silver. With respect to the forward-looking statements contained in this news release, readers are cautioned that numerous risks, uncertainties and other factors could cause our actual results to differ materially from those indicated in these statements including, but not limited to: difficulties or delays in the initiation, timing, progress and results of our preclinical trials and research and development programs relating to the development of products containing our nanocrystalline silver; our ability to maintain our collaboration with Smith & Nephew; our reliance on sal
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. NUCRYST and Smith & Nephew Revise Agreements
2. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... a next-generation customer communications archiving solution integrated with Alfresco‘s enterprise content management ... and helps organizations save millions of dollars in printing costs by digitizing ...
(Date:9/1/2015)... ... ... Elizabeth Callahan, MD, founder and medical director of SkinSmart Dermatology® , is ... treatment for volume loss in the hands. RADIESSE provides an immediate volumizing effect and ... smooth, natural-looking results that can last up to one year in most patients. Treating ...
(Date:9/1/2015)... ... September 01, 2015 , ... A new episode of “Voices In America”, ... look at the topic of arthritis. There are over 100 different types of arthritis. ... types and statistics in an effort to shed light on this important topic. , ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for the ... understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, ...
(Date:8/31/2015)... ... September 01, 2015 , ... AthleticTraining.com, provider of CEUs ... hours of new premium on-demand video Evidence Based Practice courses ... before 2014 must complete 50 CEUs before December 31, 2015, which must include ...
Breaking Medicine News(10 mins):Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2
... -- Among people with coronary stents, depression was linked to ... study period, researchers found. A coronary stent is a ... keep it open. Coronary arteries supply blood to the heart. ... with an average age 62, who underwent assessment for depression ...
... identify which skills and competencies are considered most critical ... to effectively manage opioid risk in patients treated for ... pain management, and addiction, Experts in this study identified ... in chronic pain patients as how to monitor opioids ...
... March 16 (HealthDay News) -- One man,s example hints at ... diseases before the patient actually gets sick. Researchers analyzed ... Snyder, and then used it to determine his risks for ... fragments of DNA -- and found that he was at ...
... EHEC crisis in Germany in 2011 proved that food brought ... life-threatening diseases. Nevertheless, there have been extremely few investigations ... EU along with food. The gap is now to ... almost three million Euro to cover the costs. Samples ...
... FRIDAY, March 16 (HealthDay News) -- Being unable to ... deadly outcome for older people, new research reveals. ... 52 and older, who completed a test of functional ... to understand health-related information. Specifically, the test assessed a ...
... 2012: Poor dental hygiene behaviours in patients with congenital ... with congenital heart disease floss, brush and visit the ... behaviours when it comes to alcohol, cigarettes and illicit ... congenital heart disease) also have poorer dental hygiene practices ...
Cached Medicine News:Health News:Depression Tied to Earlier Death in Heart Patients 2Health News:Study determines critical skills for PCPs to safely manage opioid risk in chronic pain patients 2Health News:Researcher Uses Genomics to Predict His Odds for Disease 2Health News:Dangerous stowaways: An EU project to look at the international spread of germs on food 2Health News:Poor Reading Skills Might Be Fatal for Older Folks 2Health News:Poor dental hygiene puts congenital heart disease patients at risk of further heart damage 2Health News:Poor dental hygiene puts congenital heart disease patients at risk of further heart damage 3Health News:Poor dental hygiene puts congenital heart disease patients at risk of further heart damage 4
(Date:9/1/2015)... Sept. 1, 2015  Abbott (NYSE: ABT ) announced ... multi-center, randomized trial comparing the safety and effectiveness of ... ® , Abbott,s market-leading, permanent drug eluting stent. The ... Japan and enrolled 400 people with coronary ... The results will be featured at a late-breaking session ...
(Date:9/1/2015)... Quebec , Sept. 1, 2015  Valeant ... TSX: VRX) today announced that its affiliate has ... which Valeant was granted an exclusive license to ... is an IL-17 receptor monoclonal antibody in development ... arthritis. Under the agreement, Valeant will hold the ...
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
Breaking Medicine Technology:Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
Inquire...
Inquire...
... optical performance, the SZX7 is designed for ... every task, from routine preparations to advanced ... best zoom ratios in its class as ... and accurate reproduction of the original specimen ...
A compact stereomicroscope that is immediately ready for operation and extremely easy to use. Focused on the essential performance features, the Stemi DV4 design concept provides optimum utility....
Medicine Products: